Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 152 Breast Neoplasms 40 Prostatic Neoplasms 31 Insulin Resistance 30 Obesity 23 Neoplasms 16 Endometrial Neoplasms 15 Pancreatic Neoplasms 14 Infertility 14 Colorectal Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Hyperandrogenism 8 Glioblastoma 8 Diabetes Mellitus 8 Squamous Cell Carcinoma of Head and Neck 7 Metabolic Syndrome 7 Melanoma 7 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Head and Neck Neoplasms 5 Diabetes Mellitus, Type 2 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Uterine Cervical Neoplasms 4

Interventions

Inositol 2 Tablets 1 Sildenafil Citrate 1 Metformin 1 Furosemide 1 Folic Acid 1 Cari-D-Tect 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pre-Eclampsia × Metformin × Clear all

NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon ⚡